The results showed that 18F-FLT and 18F-FMISO uptake finally reflected the difference in expression of tumor biomarkers (MACC1, SPON2), predicted the metastatic potential of the two tumor cells, and provided early diagnosis and metastatic potential prediction for clinical colorectal cancer liver metastasis. The gene discussed is SPON2; the disease is colorectal cancer.